Abstract
Background
Neonatal adrenoleukodystrophy (n-ALD) and X-linked ALD (X-ALD) patients present with demyelination, poor growth and progressive mental retardation. Growth factors are known to play a vital role in the development of children.
Objective
To examine the mitogenic activity of various growth factors in skin fibroblasts from n-ALD and X-ALD patients.
Methods
Skin fibroblast cultures from n-ALD and X-ALD patients, and controls were treated with 50 ng/mL of platelet-derived growth factor (PDGF), basic fibroblast growth factor (bFGF) or insulin-like growth factor-1 (IGF-1) to examine DNA synthesis by 5-bromo-2′-deoxyuridine (BrdU) incorporation. Expression of receptors for PDGF, bFGF and IGF-1 was measured by western blotting. Serum levels of IGF-1 were assayed by enzyme-linked immunosorbent assay (ELISA).
Results
Fibroblasts from n-ALD and X-ALD patients had significantly (p < 0.01) less BrdU incorporation in response to fetal bovine serum (FBS). The mitogenic effect of PDGF, bFGF and IGF-1 was significantly lower in n-ALD as compared to control and X-ALD cells. X-ALD cells showed significant impairment in IGF-1-induced DNA synthesis. Expression of the FGF receptor (FGF-R) was significantly reduced in n-ALD cells. PDGF receptor remained unaffected, and IGF-1 receptor (IGF-1R) expression and serum IGF-1 levels were significantly (p < 0.01) reduced in n-ALD and X-ALD patients as compared to controls.
Conclusions
Growth factor activity differs in n-ALD and X-ALD patients, with marked impairment of IGF-1 function through receptor down-regulation.
Acknowledgments
The authors would like to thank Mrs. Nini Mathews and Mr. BS Srivastava for their technical assistance.
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: None declared.
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.
References
1. Savage MO. Insulin-like growth factors, nutrition and growth. World Rev Nutr Diet 2013;106:52–9.10.1159/000342577Search in Google Scholar
2. Baker J, Liu JP, Robertson EJ, Efstratiadis A. Role of insulin-like growth factors in embryonic and postnatal growth. Cell 1993;75:73–82.10.1016/S0092-8674(05)80085-6Search in Google Scholar
3. Yakar S, Rosen CJ, Beamer WG, Ackert-Bicknel CL, Wu Y, et al. Circulating levels of IGF-1 directly regulate bone growth and density. J Clin Invest 2002;110:771–81.10.1172/JCI0215463Search in Google Scholar
4. Le Roith D. Seminars in medicine of the Beth Israel Deaconess Medical Center. Insulin-like growth factors. N Eng J Med 1997;336:633–40.10.1056/NEJM199702273360907Search in Google Scholar PubMed
5. Hellberg C, Ostman A, Heldin CH. PDGF and vessel maturation. Recent Results Cancer Res 2010;180:103–14.10.1007/978-3-540-78281-0_7Search in Google Scholar PubMed
6. Itoh N, Ornitz DM. Fibroblast growth factors: from molecular evolution to roles in development, metabolism and disease. J Biochem 2011;149:121–30.10.1093/jb/mvq121Search in Google Scholar PubMed PubMed Central
7. LeRoith D, Yakar S. Mechanisms of disease: metabolic effects of growth hormones and insulin-like growth factor 1. Nat Clin Pract Endocrinol Metab 2007;3:302–10.10.1038/ncpendmet0427Search in Google Scholar PubMed
8. Puche JE, Castilla-Cortazar I. Human conditions of insulin-like growth factor-1 (IGF-1) deficiency. J Translational Med 2012;10:224.10.1186/1479-5876-10-224Search in Google Scholar PubMed PubMed Central
9. Wanders RJ, Klouwer FC, Ferdinandusse S, Waterham HR, Poll-The BT. Clinical and laboratory diagnosis of peroxisomal disorders. Methods Mol Biol 2017;1595:329–42.10.1007/978-1-4939-6937-1_30Search in Google Scholar PubMed
10. Aubourg P, Wanders R. Peroxisomal disorders. Handb Clin Neurol 2013;113:1593–609.10.1016/B978-0-444-59565-2.00028-9Search in Google Scholar PubMed
11. Engelen M, Kemp S, Poll-The BT. X-linked adrenoleukodystrophy: pathogenesis and treatment. Curr Neurol Neurosci Rep 2014;14:486.10.1007/s11910-014-0486-0Search in Google Scholar PubMed
12. Farrell DF. Neonatal adrenoleukodystrophy: a clinical, pathological and biochemical study. Pediatr Neurol 2012;47:330–6.10.1016/j.pediatrneurol.2012.07.006Search in Google Scholar PubMed
13. Cai YN, Jiang MY, Liang CL, Peng MZ, Cheng J, et al. A novel ABCD1 gene mutation in a Chinese patient with X-linked adrenoleukodystrophy. J Pediatr Endocrinol Metab 2015;28:725–9.10.1515/jpem-2013-0441Search in Google Scholar PubMed
14. Argyriou A, D’Agostino MD, Braverman N. Peroxisome biogenesis disorders. Transl Sci Rare Dis 2016;1:111–44.10.3233/TRD-160003Search in Google Scholar PubMed PubMed Central
15. Astudillo L, Sabourdy F, Touati G, Levade T. Hereditary peroxisomal diseases. Presse Med 2016;45:302–12.10.1016/j.lpm.2015.05.009Search in Google Scholar PubMed
16. Dhaunsi GS, Alsaeid M, Akhtar S. Phytanic acid activates NADPH oxidase through transactivation of epidermal growth factor receptor in vascular smooth muscle cells. Lipids Health Dis 2016;15:105.10.1186/s12944-016-0273-9Search in Google Scholar PubMed PubMed Central
17. Dhaunsi GS, Al-Saeid M, Akhtar S. Phytanic acid attenuates insulin-like growth factor-1 activity via nitric oxide-mediated γ-secretase activation in rat aortic smooth muscle cells: possible implications for pathogenesis of infantile Refsum disease. Pediatr Res 2017; 81:531–6.10.1038/pr.2016.258Search in Google Scholar PubMed
18. Mastroeni R, Bensadoun JC, Charvin D, Aebischer P, Pujol A, et al. Insulin-like growth factor-1 and neurotrophin-3 gene therapy prevents motor decline in an X-linked adrenoleukodystrophy mouse model. Ann Neurol 2009;66:117–22.10.1002/ana.21677Search in Google Scholar PubMed
19. Lammeli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;60:680–5.10.1038/227680a0Search in Google Scholar PubMed
20. Dhaunsi GS, Rahbeeni Z, Al-Essa M, Ozand PT. Impaired DNA synthesis in dermal fibroblasts from Zellweger syndrome patients. J Inherit Metab Dis 1998;21:179–80.10.1023/A:1005376600257Search in Google Scholar
21. Dacremont G, Cocoquyt G, Vincent G. Measurement of very long-chain fatty acids, phytanic acid and pristanic acid in plasma and cultured fibroblasts by gas chromatography. J Inher Metab Dis 1995;18(Suppl 1):76–83.10.1007/978-94-011-9635-2_6Search in Google Scholar
22. Yang SY, Miah A, Pabari A, Winslet M. Growth Factors and their receptors in cancer metastases. Front Biosci 2011;16:531–8.10.2741/3703Search in Google Scholar PubMed
23. Randhawa R, Cohen P. The role of the insulin-like growth factor system in prenatal growth. Mol Genet Metab 2005;86:84–90.10.1016/j.ymgme.2005.07.028Search in Google Scholar PubMed
24. Froesch ER, Schmid C, Schwander J, Zapf J. Actions of insulin-like growth factors. Annu Rev Physiol 1985;47:443–67.10.1146/annurev.ph.47.030185.002303Search in Google Scholar PubMed
©2019 Walter de Gruyter GmbH, Berlin/Boston
